Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $405,855 | 214 | 67.1% |
| Travel and Lodging | $104,482 | 259 | 17.3% |
| Consulting Fee | $62,801 | 58 | 10.4% |
| Food and Beverage | $24,172 | 437 | 4.0% |
| Honoraria | $4,020 | 1 | 0.7% |
| Unspecified | $3,850 | 22 | 0.6% |
| Education | $71.24 | 7 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $113,579 | 169 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $93,504 | 166 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $85,871 | 85 | $0 (2024) |
| Travere Therapeutics, Inc. | $57,246 | 128 | $0 (2024) |
| GlaxoSmithKline, LLC. | $56,256 | 109 | $0 (2024) |
| Lilly USA, LLC | $37,809 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $34,896 | 40 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $30,742 | 36 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $27,554 | 19 | $0 (2024) |
| Vifor Pharma, Inc. | $19,881 | 27 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $150,454 | 191 | Boehringer Ingelheim Pharmaceuticals, Inc. ($33,111) |
| 2023 | $71,308 | 126 | Travere Therapeutics, Inc. ($26,013) |
| 2022 | $80,734 | 116 | Bayer HealthCare Pharmaceuticals Inc. ($29,989) |
| 2021 | $102,003 | 134 | Bayer HealthCare Pharmaceuticals Inc. ($45,192) |
| 2020 | $31,710 | 65 | GlaxoSmithKline, LLC. ($12,300) |
| 2019 | $86,893 | 175 | Amgen Inc. ($39,801) |
| 2018 | $63,027 | 111 | Amgen Inc. ($53,212) |
| 2017 | $19,122 | 80 | Amgen Inc. ($17,004) |
All Payment Transactions
998 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Ardelyx, Inc. | — | Consulting Fee | In-kind items and services | $2,450.00 | General |
| 12/19/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $32.41 | General |
| 12/19/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $17.00 | General |
| 12/19/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $11.82 | General |
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEPHROLOGY | ||||||
| 12/05/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $445.44 | General |
| 12/05/2024 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $178.88 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $51.32 | General |
| 12/05/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| 12/02/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 12/02/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| 12/02/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $133.83 | General |
| Category: Nephrology | ||||||
| 11/13/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $588.47 | General |
| 11/13/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | In-kind items and services | $259.50 | General |
| 11/13/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv, TAVNEOS | Food and Beverage | In-kind items and services | $145.50 | General |
| Category: Nephrology | ||||||
| 11/13/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $18.00 | General |
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Consulting Fee | Cash or cash equivalent | $1,425.00 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $960.00 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $119.83 | General |
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Nephrology | ||||||
| 10/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $134.41 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3 RANDOMIZED, OPEN-LABEL (SPONSOR-BLIND), ACTIVE-CONTROLLED, P | GlaxoSmithKline, LLC. | $3,453 | 19 |
| safety and efficacy linagliptin vs SU | Boehringer Ingelheim b.v. | $396.20 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 2 | 172 | 351 | $64,213 | $24,492 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 121 | 285 | $55,102 | $19,029 | 34.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 51 | 66 | $9,111 | $5,463 | 60.0% |
About Arnold Silva, MD, PHD
Arnold Silva, MD, PHD is a Internal Medicine healthcare provider based in Meridian, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497790646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Arnold Silva, MD, PHD has received a total of $605,251 in payments from pharmaceutical and medical device companies, with $150,454 received in 2024. These payments were reported across 998 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($405,855).
As a Medicare-enrolled provider, Silva has provided services to 172 Medicare beneficiaries, totaling 351 services with total Medicare billing of $24,492. Data is available for 1 year (2020–2020), covering 2 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Meridian, ID
- Active Since 06/19/2006
- Last Updated 01/21/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497790646
Products in Payments
- Parsabiv (Biological) $109,966
- LOKELMA (Drug) $92,894
- Kerendia (Drug) $85,794
- JARDIANCE (Drug) $75,905
- LUPKYNIS (Drug) $30,742
- JESDUVROQ (Drug) $29,033
- Rayaldee (Drug) $11,419
- ULTOMIRIS (Biological) $9,818
- KORSUVA (Drug) $4,541
- TARPEYO (Drug) $3,410
- Parsabiv (Drug) $3,137
- INVOKANA (Drug) $2,716
- TRADJENTA (Drug) $396.20
- Aranesp (Biological) $352.14
- ENTRESTO (Drug) $309.88
- JYNARQUE (Drug) $266.32
- Veltassa (Drug) $205.76
- KRYSTEXXA (Biological) $200.80
- LEQVIO (Drug) $189.33
- KRYSTEXXA (Drug) $175.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Meridian
Liang Wu, Md, MD
Internal Medicine — Payments: $325,715
Dr. Stephen Leblanc, M.d, M.D
Internal Medicine — Payments: $24,137
Dr. Muzaffar Rahat, M.d, M.D
Internal Medicine — Payments: $7,935
Dr. Emily Matthews, D.o, D.O
Internal Medicine — Payments: $4,952
Wilson Hannah, M.d, M.D
Internal Medicine — Payments: $4,396
Dr. Laura Alexander, D.o, D.O
Internal Medicine — Payments: $3,654